Part one of a two-part series. Link to part two. With no recourse for review, a nebulous definition of gang membership led an activist, an immigration advocate, and a Virginia legislator to fight for ...

Viking Therapeutics has reported phase 2 data on its oral obesity drug candidate, linking the peptide to weight loss of up to 12.2% after 13 weeks. But, with 38% of patients discontinuing treatment at ...